HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES

摘要

Use of a compound for the manufacture of a medicament for the treatment or prevention of a condition associated with matrix metalloproteinases or that is mediated by TNF α or enzymes involved in the shedding of L-selectin, CD23, the TNF receptors, IL-1 receptors or IL-6 receptors, wherein the compound is of the formula (I): B-X-(CH2)n-CR?2R3-CR4R5¿-COY.